Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL - 2023 PCE Oncology Spring Conferences – Hematologic Malignancies

Share

Program Content

Activities

  • Managing CLL/SLL and MCL
    Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2023

  • Managing CLL/SLL and MCL with BTKis
    Current and Novel Approaches to the Management of Patients With CLL/SLL and MCL Using BTK Inhibitors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2023

  • BTKi and BCL-2i in MCL and CLL/SLL
    Mastering the Use of BTK- and BCL2- Inhibitors in the Management of MCL and CLL/SLL
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2023

    Expires: June 26, 2024

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center 9500 Euclid Avenue CA-6
Cleveland, Ohio

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE)

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca